While as much as 50% of ovarian cancer cell lines are intrinsically TRAIL resistant [59–61], very little is known regarding the mechanisms enabling TRAIL resistance to be acquired in ovarian tumors. This evidence concerns the gene TNFSF10 and ovarian carcinoma.